Related Experiment Video
Updated: Mar 19, 2026

Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
USP11: A key regulator of cIAP2 stability and sensitivity to SMAC mimetics
1Department of Biochemistry; College of Life Science and Biotechnology; Yonsei University ; Seoul, Korea.
Abstract:
The critical function of cellular inhibitor of apoptosis proteins (cIAPs) in the protection of cancer cells from numerous apoptotic stimuli prompted the development of second mitochondria-derived activator of caspases (SMAC) mimetics. We recently addressed a novel survival pathway in which cIAP2 is induced by tumor necrosis factor-α and is stabilized by its specific deubiquitylase, USP11, rendering cells resistant to SMAC mimetics.
Insights
Cellular inhibitor of apoptosis proteins (cIAPs) protect cancer cells. A new pathway shows cIAP2, stabilized by USP11, makes cells resistant to SMAC mimetics, impacting cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Cellular inhibitor of apoptosis proteins (cIAPs) are crucial for cancer cell survival against apoptosis.
- Second mitochondria-derived activator of caspases (SMAC) mimetics were developed to target cIAPs.
- Cancer cells can develop resistance to apoptosis-inducing therapies.
Purpose of the Study:
- To investigate a novel survival pathway involving cIAP2 and USP11.
- To understand the mechanism of resistance to SMAC mimetics.
- To identify potential therapeutic targets for overcoming cancer cell resistance.
Main Methods:
- Analysis of tumor necrosis factor-alpha (TNF-α) induced pathways.
- Investigation of cIAP2 stabilization by its deubiquitylase USP11.
- Assessment of cellular response to SMAC mimetics in the presence of the novel pathway.
Main Results:
- Tumor necrosis factor-alpha (TNF-α) induces cIAP2 expression.
- The deubiquitylase USP11 stabilizes cIAP2.
- This cIAP2 stabilization confers resistance to SMAC mimetics in cancer cells.
Conclusions:
- A novel cIAP2-USP11 survival pathway contributes to cancer cell resistance.
- Targeting this pathway may overcome resistance to SMAC mimetics.
- Understanding this mechanism is vital for developing effective cancer treatments.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Nuclear Protein Sorting
Caspases
Anaphase Promoting Complex

